Comprehensive Molecular Profiling of FLT3-Mutated Acute Myeloid Leukemia (AML) Patients Treated within the Ratify Trial (Alliance C10603)

被引:0
|
作者
Jahn, Nikolaus [1 ]
Panina, Ekaterina [1 ]
Bullinger, Lars [2 ]
Dolnik, Anna [2 ]
Herzig, Julia [1 ]
Blaette, Tamara J. [2 ]
Benner, Axel [3 ]
Krzykalla, Julia [3 ]
Gathmann, Insa [4 ]
Larson, Richard A. [5 ,6 ]
Lo-Coco, Francesco [7 ]
Amadori, Sergio [7 ]
Prior, Thomas W. [8 ]
Brandwein, Joseph M. [9 ]
Appelbaum, Frederick R. [10 ]
Medeiros, Bruno C. [11 ]
Tallman, Martin S. [12 ]
Tiecke, Eva [13 ]
Pallaud, Celine [14 ]
Ehninger, Gerhard [15 ]
Heuser, Michael [16 ]
Ganser, Arnold [16 ]
Stone, Richard M. [17 ]
Thiede, Christian [15 ]
Doehner, Hartmut [1 ]
Bloomfield, Clara D. [8 ]
Doehner, Konstanze [1 ]
机构
[1] Univ Hosp Ulm, Dept Internal Med 3, Ulm, Germany
[2] Charite, Dept Hematol Oncol & Tumorimmunol, Berlin, Germany
[3] German Canc Res Ctr, Div Biostat, Heidelberg, Germany
[4] Novartis Pharma AG, Basel, Switzerland
[5] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA
[6] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA
[7] Univ Roma Tor Vergata, Rome, Italy
[8] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
[9] Princess Margaret Hosp, Dept Med Oncol & Hematol, Toronto, ON, Canada
[10] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA
[11] Stanford Univ, Ctr Canc, Stanford, CA 94305 USA
[12] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA
[13] Novartis Pharmaceut, Basel, Switzerland
[14] Novartis Pharmaceut, Oncol Precis Med, Novartis Oncol BU, Basel, Switzerland
[15] Univ Hosp Carl Gustav Carus, Internal Med 1, Dresden, Germany
[16] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany
[17] Dana Farber Partners CancerCare, Dept Med Oncol, Boston, MA USA
关键词
D O I
10.1182/blood-2018-99-115842
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1534
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial
    Nikolaus Jahn
    Ekaterina Jahn
    Maral Saadati
    Lars Bullinger
    Richard A. Larson
    Tiziana Ottone
    Sergio Amadori
    Thomas W. Prior
    Joseph M. Brandwein
    Frederick R. Appelbaum
    Bruno C. Medeiros
    Martin S. Tallman
    Gerhard Ehninger
    Michael Heuser
    Arnold Ganser
    Celine Pallaud
    Insa Gathmann
    Julia Krzykalla
    Axel Benner
    Clara D. Bloomfield
    Christian Thiede
    Richard M. Stone
    Hartmut Döhner
    Konstanze Döhner
    Leukemia, 2022, 36 : 2218 - 2227
  • [2] Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial
    Jahn, Nikolaus
    Jahn, Ekaterina
    Saadati, Maral
    Bullinger, Lars
    Larson, Richard A.
    Ottone, Tiziana
    Amadori, Sergio
    Prior, Thomas W.
    Brandwein, Joseph M.
    Appelbaum, Frederick R.
    Medeiros, Bruno C.
    Tallman, Martin S.
    Ehninger, Gerhard
    Heuser, Michael
    Ganser, Arnold
    Pallaud, Celine
    Gathmann, Insa
    Krzykalla, Julia
    Benner, Axel
    Bloomfield, Clara D.
    Thiede, Christian
    Stone, Richard M.
    Doehner, Hartmut
    Doehner, Konstanze
    LEUKEMIA, 2022, 36 (09) : 2218 - 2227
  • [3] FLT3 mutation Assay Laboratory Cross Validation: Results from the CALGB 10603/Ratify Trial in Patients with Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia (AML)
    Thiede, Christian
    Prior, Thomas W.
    Lavorgna, Serena
    Krauter, Juergen
    Barragan, Eva
    Nomdedeu, Josep
    Jansen, Joop H.
    Wei, Andrew H.
    Zhao, Weiqiang
    Li, Xiaohong
    Pallaud, Celine
    Tiecke, Eva
    Larson, Richard A.
    Bloomfield, Clara D.
    Doehner, Hartmut
    Ehninger, Gerhard
    Stone, Richard M.
    Doehner, Konstanze
    BLOOD, 2018, 132
  • [4] Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial
    Richard A. Larson
    Sumithra J. Mandrekar
    Lucas J. Huebner
    Ben L. Sanford
    Kristina Laumann
    Susan Geyer
    Clara D. Bloomfield
    Christian Thiede
    Thomas W. Prior
    Konstanze Döhner
    Guido Marcucci
    Maria Teresa Voso
    Rebecca B. Klisovic
    Ilene Galinsky
    Andrew H. Wei
    Jorge Sierra
    Miguel A. Sanz
    Joseph M. Brandwein
    Theo de Witte
    Dietger Niederwieser
    Frederick R. Appelbaum
    Bruno C. Medeiros
    Martin S. Tallman
    Jürgen Krauter
    Richard F. Schlenk
    Arnold Ganser
    Hubert Serve
    Gerhard Ehninger
    Sergio Amadori
    Insa Gathmann
    Hartmut Döhner
    Richard M. Stone
    Leukemia, 2021, 35 : 2539 - 2551
  • [5] Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial
    Larson, Richard A.
    Mandrekar, Sumithra J.
    Huebner, Lucas J.
    Sanford, Ben L.
    Laumann, Kristina
    Geyer, Susan
    Bloomfield, Clara D.
    Thiede, Christian
    Prior, Thomas W.
    Dohner, Konstanze
    Marcucci, Guido
    Voso, Maria Teresa
    Klisovic, Rebecca B.
    Galinsky, Ilene
    Wei, Andrew H.
    Sierra, Jorge
    Sanz, Miguel A.
    Brandwein, Joseph M.
    de Witte, Theo
    Niederwieser, Dietger
    Appelbaum, Frederick R.
    Medeiros, Bruno C.
    Tallman, Martin S.
    Krauter, Jurgen
    Schlenk, Richard F.
    Ganser, Arnold
    Serve, Hubert
    Ehninger, Gerhard
    Amadori, Sergio
    Gathmann, Insa
    Dohner, Hartmut
    Stone, Richard M.
    LEUKEMIA, 2021, 35 (09) : 2539 - 2551
  • [6] BURDEN OF ILLNESS (BOI) OF FLT3-MUTATED ACUTE MYELOID LEUKEMIA (AML)
    Sotak, M. L.
    Marin, M.
    Coombs, J.
    Schiller, G. J.
    Teitelbaum, A.
    VALUE IN HEALTH, 2012, 15 (04) : A101 - A102
  • [7] BURDEN OF ILLNESS OF FLT3-MUTATED ACUTE MYELOID LEUKEMIA (AML) IN THE UNITED STATES
    Sotak, M.
    Marin, M.
    Coombs, J.
    Schiller, G.
    Teitelbaum, A.
    HAEMATOLOGICA, 2012, 97 : 35 - 35
  • [8] Outcome of patients with FLT3-mutated acute myeloid leukemia in first relapse
    Ravandi, Farhad
    Kantarjian, Hagop
    Faderl, Stefan
    Garcia-Manero, Guillermo
    O'Brien, Susan
    Koller, Charles
    Pierce, Sherry
    Brandt, Mark
    Kennedy, Deborah
    Cortes, Jorge
    Beran, Miloslav
    LEUKEMIA RESEARCH, 2010, 34 (06) : 752 - 756
  • [9] Prognostic Impact of Insertion Site in Acute Myeloid Leukemia (AML) with FLT3 Internal Tandem Duplication: Results from the Ratify Study (Alliance 10603)
    Ruecker, Frank G.
    Du, Ling
    Blaette, Tamara J.
    Benner, Axel
    Krzykalla, Julia
    Gathmann, Insa
    Larson, Richard A.
    Lo-Coco, Francesco
    Amadori, Sergio
    Prior, Thomas W.
    Brandwein, Joseph M.
    Appelbaum, Frederick R.
    Medeiros, Bruno C.
    Tallman, Martin S.
    Geddes, Michelle
    Sierra, Jorge
    Tiecke, Eva
    Pallaud, Celine
    Sanz, Miguel A.
    de Witte, Theo M.
    Niederwieser, Dietger
    Ehninger, Gerhard
    Heuser, Michael
    Ganser, Arnold
    Bullinger, Lars
    Bloomfield, Clara D.
    Stone, Richard M.
    Doehner, Hartmut
    Thiede, Christian
    Dohner, Konstanze
    BLOOD, 2018, 132
  • [10] Clinical Outcomes of Patients With FLT3-Mutated Acute Myeloid Leukemia (AML): A Single-Center Retrospective Review
    Yohannan, Binoy
    Cervoni-Curet, Frances
    Sridhar, Arthi
    Yang, Wei
    Rios, Adan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S221 - S221